This meeting will provide a venue for scientists who are interested in the interface between basic epigenetic mechanisms and translational cancer research. There will be a particular focus on DNA and arginine methylation pathways as therapeutic targets. This meeting will also highlight the emerging field of ‘nucleosomics’, which leverages circulating nucleosomes and their associated histone code as biomarkers.
- Epigenetic Biomarkers and Therapeutic Vulnerabilities